Novavax (NVAX) stock price is on track...for now [LONG]

Updated
Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one.

This is purely speculation based on their pipeline. This is not financial advice.
Note
Again, here's the original post:

Novavax (NVAX) - Vaccine Testing - SARS, MERS, SARS-CoV-2 (2019)
Beyond Technical AnalysisbiotechbiotechnologyCoronavirus (COVID-19)covid-2019novavaxNVAXnvaxlongvaccine

Related publications

Disclaimer